Interleukin-6 and Outcome of Chronic Hemodialysis Patients with SARS-CoV-2 Pneumonia
<i>Background and Objectives</i>: Chronic hemodialysis (CHD) patients are at increased risk of SARS-CoV-2 infection and the related complications and mortality of COVID-19 due to the high rate of comorbidities combined with advanced age. This observational study investigated the clinical...
Main Authors: | Gabriele Donati, Lorenzo Gasperoni, Fulvia Zappulo, Anna Scrivo, Marianna Napoli, Federica Di Filippo, Maria Cappuccilli, Rita Mancini, Gaetano La Manna |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/11/1659 |
Similar Items
-
Immunological Effects of a Single Hemodialysis Treatment
by: Andrea Angeletti, et al.
Published: (2020-02-01) -
Toxin Removal and Inflammatory State Modulation during Online Hemodiafiltration Using Two Different Dialyzers (TRIAD2 Study)
by: Gabriele Donati, et al.
Published: (2021-04-01) -
Dynamics of Interleukin-4 and Interleukin-8 in Young Children with Complicated Pneumonia Secondary to Iron-Deficiency Anemia
by: L. I. Haridzhuk
Published: (2016-06-01) -
Clinical Role of Serum Interleukin-17A in the Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children
by: Zhao J, et al.
Published: (2020-03-01) -
Physical Activity versus Sclerostin and Interleukin 6 Concentration in Patients Receiving Renal Replacement Therapy by Hemodialysis
by: Turoń-Skrzypińska A, et al.
Published: (2020-09-01)